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Figure 1. Distribution of synovitis. Frequencies of deﬁnite synovial thickening at
speciﬁc subregions at the knee. sPat = suprapatellar; iC = intercondylar; iPat
= infrapatellar; pmPat = medial parapatellar; plPat = lateral parapatellar; Acl =
around ACL; Pcl = around PCL; mMen = medial perimeniscal; lMen = lateral
perimeniscal; LB = near losse bodies; Bak = Baker’s cyst.
Figure 2. Examples of localized synovitis in an osteoarthritic knee. Sagittal T1w
FS CE images. A. Grade 3 synovitis in the subregion posterior to the PCL (ar-
rows). B. Grade 3 synovitis in the suprapatellar subregion (arrowheads).
Figure 3. Discrepancy of assessment of joint effusion. A. On axial proton-density
weighted fat suppressed image, grade 3 hyperintense ﬂuid-equivalent signal is
observed in the joint cavity (white arrows). Marked capsular distension is seen.
B. On axial T1 weighted fat suppressed constrast-enhanced image, hypointense
ﬂuid-equivalent signal in the joint cavity is markedly less when compared to A
(black arrows). However, in addition severe synovial thickening and enhance-
ment is seen (arrowheads).
Conclusions: Synovitis in OA is common with the commonest
site being the region posterior to the PCL. Joint effusion as
measured on PD FS images does not only represent effusion but
also synovial thickening. Disagreement of effusion assessment
is due to overestimation of effusion on the PD FS sequence.
Deﬁnite synovitis was present in the majority of knees without
a measurable effusion. Further work is required to explore the
clinical consequences of synovial enhancement at the different
sites.
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Purpose: Subchondral bone marrow lesions (BMLs) are a hall-
mark feature of osteoarthritis on MRI. BMLs are observed regularly
in conjunction with adjacent cartilage alterations. Higher grades
of cartilage loss seem to be associated with higher prevalence
of concomitant BMLs. As the disease progresses, an increase
in BML volume is seen in the subchondral bone in many pa-
tients, which is positively correlated with an increase in cartilage
loss and radiographic joint space narrowing in the same region.
Semiquantitative assessment of BMLs is commonly performed on
fat-suppressed T2-weighted or proton density-weighted fast spin
echo sequences. It has been suggested that BMLs may also be
assessed on gradient echo-type sequences. The aim of the study
was to compare semiquantitative assessment of BMLs using the
dual echo at steady state with water excitation- (DESS-) and inter-
mediate weighted (IW) fat suppressed (FS) turbo spin echo (TSE)
- sequences at 3 T MRI.
Methods: The JOG-study includes 177 subjects aged 35-65 with
frequent knee pain. 3 T MRI of both knees was performed at
baseline with an identical sequence protocol that is used for semi-
quantitative scoring in the Osteoarthritis Initiative (OAI): sagittal
IW TSE FS, sagittal DESS with water excitation (WE), axial ref-
ormation of sagittal DESS WE, coronal reformation of sagittal
DESS WE, coronal IW TSE. BMLs were scored according to
the Whole Organ Magnetic Resonance Imaging Score (WORMS)
using all ﬁve sequences. Subsequently, 200 BMLs (63 knees)
were randomly selected. In a consensus-reading of two experi-
enced musculoskeletal radiologists (AG, FWR) size of BMLs was
re-scored in separate sessions on the sagittal IW TSE FS- and
DESS-sequences according to WORMS. Conﬁdence of the differ-
entiation between cystic and non-cystic part of BMLs was recorded
on a scale from 0-3. In an additional side-by-side reading superi-
ority of cyst delineation was further recorded for both sequences.
Wilcoxon and Chi-square statistics were used to determine differ-
ences between the two sequences.
Results: 81 (40.5%) BMLs were in the medial tibio-femoral,
24 (12%) in the lateral tibio-femoral and 94 (47.5%) in the
patellofemoral compartments. On the IW sequence 67 (33.5%)
BMLs were scored as grade 1, 84 (42%) as grade 2 and 49
(24.5%) as grade 3. On the DESS 100 (50%) BMLs were grade
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1, 7 (3.5%) grade 2 and no grade 3 lesions were observed. 93
(46.5%) BMLs that were seen on the IW TSE FS were not de-
tectable on the DESS. Assessment of BML size was superior for
the sagittal IW TSE FS sequence (P<0.001). 113 cystic lesions
were observed. No signiﬁcant difference was found for differenti-
ation between non-cystic and cystic part of BMLs. In 89 (78.8%)
cases the DESS delineated the cystic lesions superiorly. No differ-
ence between the sequences was seen in 24 (21.2%) cases. The
DESS sequence showed superiority for cyst delineation (p<0.001).
Conclusions: Full extent of non-cystic BMLs is only shown on the
IW TSE FS sequence. The DESS sequence helps in the differ-
entiation of non-cystic vs. cystic parts of BMLs as it depicted the
cyst delineation superiorly. Both sequences are complementary,
but size of BMLs should only be assessed on the IW TSE FS
sequence.
Semiquantitative assessment of non-cystic subchondral bone mar-
row lesions should be performed on sequences that depict these
lesions to their maximum extent.
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Purpose: The absence of a proxy biomarker for measurement of
structural progression of knee OA has been a major impediment to
development of disease-modifying interventions for this common,
disabling disorder. Several novel technological approaches have
emerged with the potential to measure changes in articular carti-
lage. Two of these include T1-mapping of cartilage after contrast
administration (delayed Gadolinium Enhanced MRI of Cartilage,
dGEMRIC) and T2-mapping.
We performed a pilot study to test ability of these parameters
to detect changes in cartilage characteristics in human knee OA
following a 24-week course of oral proprietary collagen hydrolysate
Fortigel®. This is a nutritional product produced by GELITA shown
to have anabolic effects on chondrocytes in-vivo and reduce
progression of OA in animal models.
Methods: We performed a randomized, placebo-controlled,
double-blind, 24-week clinical trial of 10 grams collagen hy-
drolysate orally once per day among 30 participants with symp-
tomatic knee OA. There was a planned option for a further 24-week
extension of the clinical trial based on a blinded assessment (A
vs. B) of the 24-week data by the study Data & Safety Monitoring
Board. Fortigel® and placebo formulations were indistinguishable
in appearance and ﬂavor. Treatment assignment was according
to a blocked randomization scheme, stratiﬁed by body mass in-
dex (BMI). We permitted participants to take acetaminophen or
non-steroidal anti-inﬂammatory drugs at their regular dose and
tramadol for breakthrough pain. Participants received clinical as-
sessment every 8 weeks and dGEMRIC and T2 MRI scans at
baseline, 24 and 48 weeks. dGEMRIC index and T2 values were
calculated in 6 speciﬁed regions of interest in cartilage. The
primary outcome was change in dGEMRIC index in the study
knee hyaline cartilage. Secondary endpoints included change in
cartilage mean T2 relaxation time, WOMAC scores, timed walk
and chair stand tests. We tested for differences between groups
using a Wilcoxon Rank Sum (non-parametric) test since there
was evidence of a non-normality of distribution of study out-
comes.
Results: The assignment groups were balanced in most respects
but the placebo group had slightly more functional limitation (table
1). The DSMB recommended continuation for the full 48 weeks.
During the ﬁrst 24 weeks, the dGEMRIC indices in the medial
and lateral tibial regions fell in the placebo group but increased in
the treatment group (table 2). Signiﬁcant trends were not seen for
other regions of interest or T2 values. The clinical indices broadly
improved in both groups without any major differences between
them (e.g. change in WOMAC pain at 24 weeks: -1.4 versus
-1.5, p=ns). Analysis of the 48-week outcomes showed no further
change.
Table 1. Demographics and baseline characteristics of participants
Placebo (n=15) CH (n=15)
Age, y, mean (SD) 60.3 (8.5) 58.9 (8.0)
Gender, female, n (%) 9 (60%) 9 (60%)
Race, white, n (%) 13 (87%) 14 (93%)
BMI, kg/m2, mean (SD) 31.1 (7.2) 29.9 (4.6)
KL score = 2, n (%) 13 (87%) 14 (93%)
dGEMRIC Index, msec (SD)
Medial Tibia 408 (80) 366 (81)
Central Medial Femur 413 (80) 421 (56)
Posterior Medial Femur 425 (74) 435 (62)
Lateral Tibia 450 (89) 426 (89)
Central Lateral Femur 414 (76) 430 (67)
Posterior Lateral Femur 400 (52) 414 (83)
WOMAC (SD)
Pain 5.8 (3.0) 4.6 (2.6)
Stiffness 2.8 (1.5) 2.9 (1.1)
Function 20.6 (10.9) 12.9 (8.7)*
Total 29.2 (13.9) 20.3 (10.5)
20-meter walk, median, sec 17.9 16.2
Chair stand, sec (SD) 17.7 (5.9) 14.7 (3.5)
Table 2. Median Change in dGEMRIC Index from Baseline to 24 and 48 weeks
Placebo Group CH Group
0-24 weeks 0-48 weeks 0-24 weeks 0-48 weeks
Medial Tibia -38.0 14.0 28.0* 47.0
Lateral Tibia -33.5 -1.0 40.0* 28.0
Central Medial Femur 21.0 -5.0 -18.0 17.0
Posterior Medial Femur 22.5 -6.0 26.0 15.0
Central Lateral Femur 26.0 2.0 -17.0 -6.0
Posterior Lateral Femur 30.5 19.0 36.0 32.0
*Between group p-value <0.05.
Conclusions: In summary, the dGEMRIC index was able to dis-
criminate between treatment and placebo groups in the tibial
regions. The directionality of this change is compatible with an
increase in proteoglycan content of hyaline cartilage in those re-
ceiving Fortigel® and a decrease among those on the placebo.
The sample size was small, so these data should be regarded as
preliminary.
406
SODIUM MRI OF ARTICULAR CARTILAGE AFTER
ANTERIOR CRUCIATE LIGAMENT INJURY
G. Gold1, S. Koo2, E. Starosweicki1, R. Watkins1,
B. Hargreaves1, N. Bangerter3
1Stanford Univ., Stanford, CA; 2Chung Ang Univerity, Seoul,
Republic of Korea; 3Brigham Young Univ., Provo, UT
Purpose: Early degenerative changes in articular cartilage leading
to osteoarthritis are accompanied by glycosaminoglycan (GAG)
depletion in the cartilage matrix. Subjects with prior tears to the
anterior cruciate ligament (ACL) may show early development
of osteoarthritis. Sodium MRI has been shown to correlate with
GAG concentration, and may be useful in detecting and tracking
early GAG depletion. Sodium MRI is challenging due to relatively
